Differential metabolism of choline supplements in adult volunteers.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 01 02 2021
accepted: 05 07 2021
pubmed: 22 7 2021
medline: 27 1 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

Adequate intake of choline is essential for growth and homeostasis, but its supply does often not meet requirements. Choline deficiency decreases phosphatidylcholine (PC) and betaine synthesis, resulting in organ pathology, especially of liver, lung, and brain. This is of particular clinical importance in preterm infants and cystic fibrosis patients. We compared four different choline supplements for their impact on plasma concentration and kinetics of choline, betaine as a methyl donor and trimethylamine oxide (TMAO) as a marker of bacterial degradation prior to absorption. Prospective randomized cross-over study (1/2020-4/2020) in six healthy adult men. Participants received a single dose of 550 mg/d choline equivalent in the form of choline chloride, choline bitartrate, α-glycerophosphocholine (GPC), and egg-PC in randomized sequence at least 1 week apart. Blood was taken from t = - 0.1-6 h after supplement intake. Choline, betaine, TMAO, and total PC concentrations were analyzed by tandem mass spectrometry. Results are shown as medians and interquartile range. There was no difference in the AUC of choline plasma concentrations after intake of the different supplements. Individual plasma kinetics of choline and betaine differed and concentrations peaked latest for PC (at ≈3 h). All supplements similarly increased plasma betaine. All water-soluble supplements rapidly increased TMAO, whereas egg-PC did not. All supplements tested rapidly increased choline and betaine levels to a similar extent, with egg-PC showing the latest peak. Assuming that TMAO may have undesirable effects, egg-PC might be best suited for choline supplementation in adults. This study was registered at "Deutsches Register Klinischer Studien" (DRKS) (German Register for Clinical Studies), 17.01.2020, DRKS00020454.

Sections du résumé

BACKGROUND BACKGROUND
Adequate intake of choline is essential for growth and homeostasis, but its supply does often not meet requirements. Choline deficiency decreases phosphatidylcholine (PC) and betaine synthesis, resulting in organ pathology, especially of liver, lung, and brain. This is of particular clinical importance in preterm infants and cystic fibrosis patients. We compared four different choline supplements for their impact on plasma concentration and kinetics of choline, betaine as a methyl donor and trimethylamine oxide (TMAO) as a marker of bacterial degradation prior to absorption.
METHODS METHODS
Prospective randomized cross-over study (1/2020-4/2020) in six healthy adult men. Participants received a single dose of 550 mg/d choline equivalent in the form of choline chloride, choline bitartrate, α-glycerophosphocholine (GPC), and egg-PC in randomized sequence at least 1 week apart. Blood was taken from t = - 0.1-6 h after supplement intake. Choline, betaine, TMAO, and total PC concentrations were analyzed by tandem mass spectrometry. Results are shown as medians and interquartile range.
RESULTS RESULTS
There was no difference in the AUC of choline plasma concentrations after intake of the different supplements. Individual plasma kinetics of choline and betaine differed and concentrations peaked latest for PC (at ≈3 h). All supplements similarly increased plasma betaine. All water-soluble supplements rapidly increased TMAO, whereas egg-PC did not.
CONCLUSION CONCLUSIONS
All supplements tested rapidly increased choline and betaine levels to a similar extent, with egg-PC showing the latest peak. Assuming that TMAO may have undesirable effects, egg-PC might be best suited for choline supplementation in adults.
STUDY REGISTRATION BACKGROUND
This study was registered at "Deutsches Register Klinischer Studien" (DRKS) (German Register for Clinical Studies), 17.01.2020, DRKS00020454.

Identifiants

pubmed: 34287673
doi: 10.1007/s00394-021-02637-6
pii: 10.1007/s00394-021-02637-6
pmc: PMC8783899
doi:

Substances chimiques

Betaine 3SCV180C9W
Choline N91BDP6H0X

Banques de données

DRKS
['DRKS00020454']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-230

Informations de copyright

© 2021. The Author(s).

Références

Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G425-G445
pubmed: 30576217
Cell Physiol Biochem. 2015;35(4):1437-53
pubmed: 25791258
Semin Liver Dis. 1996 May;16(2):191-200
pubmed: 8781023
Nutr Rev. 2009 Nov;67(11):615-23
pubmed: 19906248
Am J Respir Crit Care Med. 2004 Jul 1;170(1):54-8
pubmed: 15044202
Nutrients. 2019 Oct 22;11(10):
pubmed: 31652561
Am J Clin Nutr. 2011 Mar;93(3):564-8
pubmed: 21228267
J Nutr. 2003 May;133(5):1302-7
pubmed: 12730414
Crit Rev Clin Lab Sci. 1998 Dec;35(6):461-87
pubmed: 9885772
J Am Diet Assoc. 2010 Aug;110(8):1198-206
pubmed: 20656095
Annu Rev Nutr. 2006;26:229-50
pubmed: 16848706
J Lipid Res. 1991 Oct;32(10):1539-70
pubmed: 1797938
Arch Physiol Biochem. 2002 Dec;110(5):393-9
pubmed: 12530624
Am J Clin Nutr. 2007 Mar;85(3):702-8
pubmed: 17344490
Neurology. 1980 Nov;30(11):1226-9
pubmed: 7191517
Metabolism. 1992 Feb;41(2):135-6
pubmed: 1736035
Nutrients. 2019 Mar 18;11(3):
pubmed: 30889905
Eur J Nutr. 2021 Jun;60(4):1737-1759
pubmed: 32797252
Nutrients. 2020 Dec 13;12(12):
pubmed: 33322176
J Lipid Res. 2011 Feb;52(2):399-407
pubmed: 21068006
Nutrients. 2020 Jul 25;12(8):
pubmed: 32722424
Am J Clin Nutr. 2005 Mar;81(3):686-91
pubmed: 15755840
Gastroenterology. 2009 Nov;137(5 Suppl):S119-28
pubmed: 19874943
Eur J Nutr. 2015 Aug;54(5):733-41
pubmed: 25148882
FASEB J. 2014 Jul;28(7):2970-8
pubmed: 24671709
Eur J Nutr. 2019 Apr;58(3):931-945
pubmed: 30298207
Eur J Nutr. 2013 Apr;52(3):1269-78
pubmed: 22961562
Nutrients. 2018 Oct 16;10(10):
pubmed: 30332744
Nutrients. 2019 Nov 13;11(11):
pubmed: 31766273
Eur J Nutr. 2017 Jun;56(4):1733-1742
pubmed: 27164830
Nature. 2011 Apr 7;472(7341):57-63
pubmed: 21475195
Pediatr Res. 2003 Apr;53(4):589-93
pubmed: 12612207
J Biol Chem. 2005 Nov 11;280(45):37798-802
pubmed: 16144842
N Engl J Med. 2013 Apr 25;368(17):1575-84
pubmed: 23614584

Auteurs

Katrin A Böckmann (KA)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany. katrin.boeckmann@med.uni-tuebingen.de.

Axel R Franz (AR)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.
Center for Pediatric Clinical Studies, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Michaela Minarski (M)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Anna Shunova (A)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Christian A Maiwald (CA)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Julian Schwarz (J)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Maximilian Gross (M)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Christian F Poets (CF)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Wolfgang Bernhard (W)

Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH